Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Hemelrijck, M. van"'
Autor:
Beyer, K., Moris, L., Lardas, M., Omar, M.I., Healey, J., Tripathee, S., Gandaglia, G., Venderbos, L.D.F., Vradi, E., Broeck, T. Van den, Willemse, P.P., Antunes-Lopes, T., Pacheco-Figueiredo, L., Monagas, S., Esperto, F., Flaherty, S., Devecseri, Z., Lam, T.B., Williamson, P.R., Heer, R., Smith, E.J., Asiimwe, A., Huber, J., Roobol, M.J., Zong, J., Mason, M., Cornford, P., Mottet, N., MacLennan, S.J., N'Dow, J., Briganti, A., Huisman, H.J., MacLennan, S., Hemelrijck, M. Van
Publikováno v:
European Urology, 81(5), 503-514. Elsevier
European Urology, 81, 503-514
European Urology, 81, 5, pp. 503-514
European Urology
European Urology, 81, 503-514
European Urology, 81, 5, pp. 503-514
European Urology
Contains fulltext : 288445.pdf (Publisher’s version ) (Open Access) CONTEXT: Harmonisation of outcome reporting and definitions for clinical trials and routine patient records can enable health care systems to provide more efficient outcome-driven
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccfdea01598f7ef85d1cd152c9161d7b
https://pure.eur.nl/en/publications/1f028a11-f893-45e0-acf2-b79240d9fac0
https://pure.eur.nl/en/publications/1f028a11-f893-45e0-acf2-b79240d9fac0
Autor:
Beyer, K., Moris, L., Lardas, M., Haire, A., Barletta, F., Scuderi, S., Molnar, M., Herrera, R., Rauf, A., Campi, R., Greco, I., Shiranov, K., Dabestani, S., Broeck, T. Van den, Arun, S., Gacci, M., Gandaglia, G., Omar, M.I., MacLennan, S., Roobol, M.J., Farahmand, B., Vradi, E., Devecseri, Z., Asiimwe, A., Zong, J., MacLennan, S.J., Collette, L., J, N.D., Briganti, A., Huisman, H.J., Bjartell, A., Hemelrijck, M. Van
Publikováno v:
BMJ Open, 12
BMJ Open, 12, 4
BMJ Open, 12, 4
ObjectivesAs part of the PIONEER Consortium objectives, we have explored which diagnostic and prognostic factors (DPFs) are available in relation to our previously defined clinician and patient-reported outcomes for prostate cancer (PCa).DesignWe per
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c971804c93af4f8ee1faf014b7c5fa14
https://hdl.handle.net/2066/288442
https://hdl.handle.net/2066/288442
Autor:
Omar, M.I., Roobol, M.J., Ribal, M.J., Abbott, T., Agapow, P.-M., Araujo, S., Asiimwe, A., Auffray, C., Balaur, I., Beyer, K., Bernini, C., Bjartell, A., Briganti, A., Butler-Ransohoff, J.-E., Campi, R., Cavelaars, M., Meulder, B. de, Devecseri, Z., Voss, M.D., Dimitropoulos, K., Evans-Axelsson, S., Franks, B., Fullwood, L., Horgan, D., Smith, E.J., Kiran, A., Kivinummi, K., Lambrecht, M., Lancet, D., Lindgren, P., MacLennan, S., Nogueira, M.M., Moen, F., Moinat, M., Papineni, K., Reich, C., Reiche, K., Rogiers, S., Sartini, C., Bochove, K. van, Diggelen, F. van, Hemelrijck, M. van, Poppel, H. van, Zong, J., N'Dow, J., Horn, F., Kreuz, M.
The originally published article contained errors in Figure 1 and did not reflect the current organization of the PIONEER consortium. The figure has been corrected in the HTML and PDF versions of the manuscript to reflect the correct organization of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______610::0ae588f52556740230e263b5d1270bc2
https://publica.fraunhofer.de/handle/publica/264517
https://publica.fraunhofer.de/handle/publica/264517
Autor:
Kerri Beckmann, Elizabeth C Smyth, Cara R. Baker, Andrew Davies, Mark Kelly, R Bott, William R. C. Knight, James A. Gossage, Hemelrijck M Van, Michelle J. Wilkinson, W Allum, David Cunningham, J Zylstra, N. Maisey
Publikováno v:
Diseases of the Esophagus. 32
Aim The aim of this study was to assess the survival benefit of adjuvant therapy in R0 resection patients following neo-adjuvant chemotherapy and surgery for lower oesophageal and GOJ adenocarcinoma. Background & Methods The role of adjuvant therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7bdba52aa69a3985f6279544ff2961ea
https://doi.org/10.1093/dote/doz092.96
https://doi.org/10.1093/dote/doz092.96
Autor:
Nowinski, S., Quist, J., Baker, A.M., Graham, T.A., Lombardelli, C., Gillett, C., Loda, M., Chandra, A., Hemelrijck, M. Van, Grigoriadis, A.
Publikováno v:
In ESMO Open 30 June-3 July 2018 3 Supplement 2:A141-A141
Autor:
Ratti, M.M., Gandaglia, G., Alleva, E., Leardini, L., Sisca, E.S., Derevianko, A., Furnari, F., Ferracini, S. Mazzoleni, Beyer, K., Moss, C., Pellegrino, F., Sorce, G., Barletta, F., Scuderi, S., Omar, M.I., MacLennan, S., Williamson, P.R., Zong, J., MacLennan, S.J., Mottet, N., Cornford, P., Aiyegbusi, O.L., Hemelrijck, M. Van, N'Dow, J., Briganti, A., Huisman, H.J.
Publikováno v:
European Urology Oncology, 5, 153-163
European Urology Oncology, 5, 2, pp. 153-163
European Urology Oncology
European Urology Oncology, 5, 2, pp. 153-163
European Urology Oncology
Contains fulltext : 288444.pdf (Publisher’s version ) (Open Access) CONTEXT: Prostate cancer (PCa) is the second most common cancer among men worldwide. Urinary, bowel, and sexual function, as well as hormonal symptoms and health-related quality of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7d64b337788f364b93d8cdb220a7f37